2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1487663928 MD
Verify on CMS →

ROBERT COLEMAN, MD

Endocrinology, Diabetes & Metabolism Physician in CELEBRATION, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
6K
Medicare Part D claims · 743 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
55%
generic claims · 45% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
78.0121/100
▼ 5 pts below national avg 83.1 · [object Object]
Industry payments
$333.27
11 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: ROBERT COLEMAN, MD is a Endocrinology, Diabetes & Metabolism Physician ([object Object]) practicing in CELEBRATION, Florida with a Medicare Part D prescribing footprint of 6K claims across 743 beneficiaries — 45% brand-name prescribing . Their CMS MIPS Final Score of 78.0121/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $333.27 across 11 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: ROBERT COLEMAN, MD reported a CMS MIPS final score of 78.0121 out of 100, below the 83.1 national average, and filed 6,391 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

ROBERT COLEMAN, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

ROBERT COLEMAN, MD at a glance

Below national average

NPI registry status

Active

Issued 08/05/2006

NPI 1487663928

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

7,852 US NPIs in this specialty

Medicare Part D claims

6,391 142% vs specialty avg

2023 prescription claims

Specialty avg: 2,639

MIPS final score

78.0121/100 5.0878999999999905% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Florida

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Florida providers

Florida providers

Endocrinology, Diabetes & Metabolism Physician share within Florida

1. Endocrinology, Diabetes & Metabolism Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Endocrinology, Diabetes & Metabolism Physician share within Florida

Medicare quality performance — MIPS

ROBERT COLEMAN, MD's 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average

Below national average
MIPS Final Score
78.0121/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 78.0121/100 vs national avg 83.1

0%100%National avg83%78%
MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 78.0121/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ROBERT COLEMAN, MD is a Endocrinology, Diabetes & Metabolism Physician provider practicing in CELEBRATION, Florida, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1487663928. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

ROBERT COLEMAN, MD appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding MD credentials at 410 CELEBRATION PLACE, CELEBRATION, FL, 34747, with a listed phone of (407) 303-4855. NPI 1487663928 was issued on 08/05/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what COLEMAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 6,391 prescription claims written by this provider, covering 743 Medicare beneficiaries and totaling roughly $3.4 million in drug spend, split 45% brand-name and 55% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 78.0121/100 for the 2023 performance year (Quality 57.5188, Cost 69.1882), compared with the national average of 83.1.

Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

410 CELEBRATION PLACE
CELEBRATION, FL 34747

Provider Details

NPI 1487663928
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials MD
Gender Male
NPI Issued 08/05/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

78.0121
Final Score
Avg: 83.1
57.5188
Quality
69.1882
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where ROBERT COLEMAN, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

FLORIDA HOSPITAL MEDICAL GROUP INC
CELEBRATION, FL

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ROBERT COLEMAN, MD. Source: openpaymentsdata.cms.gov.

Total received

$333

Largest payer

Aadi Bioscience, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Florida FLDOH 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to ROBERT COLEMAN, MD. To verify ROBERT COLEMAN, MD's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases

FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

ROBERT COLEMAN, MD — brand share 45.0%
Specialty average (est.)

45% brand-name claims vs 55% generic, on 6,391 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

6,391
Total Claims
$3.4M
Total Drug Cost
743
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
16,036
Total Day Supply
477,885
Brand vs Generic
45% brand / 55% generic
Brand Drug Cost
$3.2M
Generic Drug Cost
$79K
Antibiotic Claims
15

Patient Demographics

Average Patient Age
71.4 years
Avg HCC Risk Score
1.65
Gender Split
60% female / 40% male
Age Distribution
<65: 99, 65-74: 359, 75-84: 262, 85+: 23

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Levothyroxine Sodium
569
Metformin Hcl Er
Metformin Hcl
320
Metformin Hcl
304
Ozempic
Semaglutide
275
Synthroid
Levothyroxine Sodium
266
Atorvastatin Calcium
265
Pioglitazone Hcl
261
Jardiance
Empagliflozin
224
Trulicity
Dulaglutide
183
Farxiga
Dapagliflozin Propanediol
178

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How ROBERT COLEMAN, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider

ROBERT COLEMAN, MD's 6,391 claims are above the specialty average of 2,639.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Florida

Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as COLEMAN.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is ROBERT COLEMAN, MD's specialty?
ROBERT COLEMAN, MD specializes in Endocrinology, Diabetes & Metabolism Physician and practices in CELEBRATION, Florida. Credentials: MD.
How much does ROBERT COLEMAN, MD prescribe under Medicare Part D?
In 2023, ROBERT COLEMAN, MD wrote 6,391 Medicare Part D claims totaling $3.4M in drug costs for 743 beneficiaries.
What is ROBERT COLEMAN, MD's Medicare quality score?
ROBERT COLEMAN, MD has a CMS MIPS Final Score of 78.0121/100 (Quality: 57.5188, Cost: 69.1882). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is ROBERT COLEMAN, MD located?
ROBERT COLEMAN, MD is located at 410 CELEBRATION PLACE, CELEBRATION, FL, 34747. Phone: (407) 303-4855.
What is ROBERT COLEMAN, MD's NPI number?
ROBERT COLEMAN, MD's National Provider Identifier (NPI) is 1487663928, issued on 08/05/2006.
Does ROBERT COLEMAN, MD prescribe more brand-name or generic drugs?
ROBERT COLEMAN, MD's prescribing is 45% brand-name and 55% generic drugs by claim count, with $3.2M in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does ROBERT COLEMAN, MD prescribe most often?
Based on 2023 Medicare Part D data, ROBERT COLEMAN, MD's most frequently prescribed drugs include Levothyroxine Sodium, Metformin Hcl Er, Metformin Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ROBERT COLEMAN, MD accept Medicare?
ROBERT COLEMAN, MD appears in CMS Medicare data with 6,391 Part D claims and 743 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ROBERT COLEMAN, MD's credentials?
ROBERT COLEMAN, MD's NPI is 1487663928 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology